German healthcare group Merc is looking for acquisitions and collaborations with start-ups to grow its drugs business in the United States, a senior Merck official said.
Healthcare Health/Fitness
Hong Kong billionaire Li Ka-shing prepares for Watson IPO
Just months after pulling out of a planned multi-billion dollar sale of his grocery chain, Hong Kong billionaire Li Ka-shing has started the process for Waston's initial public offering. The global retail business is set to float next year.
Experts urge CROs to be ready for exit of private equity
The exit of private equity from their investments in contract research organizations (CROs) could threaten its growth, says two financial experts at Partnerships in Clinical Trials.
KKR to acquire minority stake in Gland Pharma for USD200 million
American private equity firm KKR & Co LP reportedly agreed to commit USD200 million in Indian injectables manufacturing company Gland Pharma. The deal could put the company's valuation around USD600 million to USD650 million.
23andMe defends genetic testing product
23andMe Chief Executive Officer Anne Wojcicki defended her company's genetic testing product and stands by the data on the accuracy of their results after the public warning letter issued by the US Food and Drug Administration.
Latest News
Indian company TTK Group is moving forward with its plans to seize back market share it lost after the ending of its partnership with Reckitt Benckiser Group Plc a year ago by increasing sales shipments of its own brand of prophylactics.
Despite the offer at a 27% premium from yesterday's trading close of Algeta ASA's shares, the Norwegian company said through a spokesperson that it does not guarantee that it will accept Bayer AG's offer.
Tyber Medical, a privately-held medical device company, said it was able to successfully close its initial funding round. Names of the private equity investors who participated, as well as the amount raised were not disclosed.
France-based biopharmaceutical company Transgene supported the proposal of South Korean contract research and development firm SillaJen Inc to acquire biotherapeutics company Jennerex. Transgene owns 8.5% of Jennerex.
US-based generic drug manufacturer Mylan and two Indian pharmaceutical firms are in talks to buy Chennai-based Bafna Pharmaceuticals for an undisclosed amount, according to two sources familiar with the transaction.
Ramot Tel Aviv University Ltd secured USD17 million in funding for its Technology Innovation Momentum Fund, which will invest in breakthrough technologies in various industries.
French investment firm Wendel and Nordic Capital are the remaining bidders for Germany's medical patch maker LTS Lohmann. The acquisition deal could bring in EUR1.2 billion to the company owned by Novartis, BWK and German tycoon Dietmar Hopp.
American private equity firm Bain Capital was said to be in talks with other private equity firms to sell its insurance software business Applied Systems Inc. Sources said that the sale could bring in USD1 billion to the investment firm.
German-based pharmaceutical giant Bayer is preparing an acquisition bid amounting to NOK306 (USD49.9) per share for its Norwegian partner Algeta, according to a German newspaper.
